4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-15-073788
SVP, General Counsel, Sec. sold 1,484 shares at $8.67 ($12,860)
From the SEC's structured data for this filing
Trades in this filing
Hadas Nicole R. · SVP, General Counsel, Sec.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-10-02 | Sale : show line 1 in the form | −1,484 | $8.67 | $12,860 | 65,260 | D |
| Open-market sales · 1,484 sh · avg $8.67 · $12,860 | ||||||
Loading xslF345X03/doc4.xml…